Latest

MEB Citrix systems switched off

19-01-2020 | 20:00

Out of precaution the MEB Citrix systems have been switched off, due to the recent Citrix safety warnings. As a result, MEB ...

Shorter timetable for procedure for changing parallel package leaflet

30-12-2019 | 08:38

The Medicines Evaluation Board (MEB) has decided to implement a shorter timetable for the procedure for changing the parallel ...

MEB fee rate change as of January 2020

24-12-2019 | 12:00

The Medicines Evaluation Board (MEB) is increasing the fee rates for authorisation applications, authorisation changes and the ...

Regulatory Science Magazine 9: opioids and Real World Data

12-12-2019 | 13:30

Today the Medicines Evaluation Board (MEB) publishes the 9th edition of its Regulatory Science Magazine. This edition features ...

Change for consultation procedures resulting from the implementation of Medical Device Regulation (MDR)

21-11-2019 | 13:30

As of 26 May 2020 the Medicines Evaluation Board (MEB) will provide advice under the new Medical Device Regulation (MDR, EU ...

Changes to product information must be made more quickly

14-10-2019 | 14:00

Within Europe agreements are regularly made regarding changes to information on medicinal products. In many cases it takes too ...

Year-end withdrawals medicines for human use

17-09-2019 | 09:00

Withdrawal requests for (parallel) marketing authorisations per 31 December, the so-called 'year-end withdrawals' for medicines ...

8th edition Regulatory Science Magazine

04-06-2019 | 18:30

Today the Medicine Evaluation Board (MEB) publishes the 8th edition of its Regulatory Science Magazine. This edition focuses on ...

MEB and ZIN start pilot to accelerate access to innovative medicines

09-05-2019 | 08:00

Accelerating patient access to reimbursable innovative medicines has been on the wish list of the government, patient ...

Amended policy relating to patented indications

08-05-2019 | 13:00

The Medicines Evaluation Board (MEB) will no longer publish the full product information about the active substance of generic ...

The MEB in 2018: A focus on core tasks

11-04-2019 | 16:00

'At the MEB life is never boring'. This is how MEB chair Ton de Boer and director Hugo Hurts start their review of 2018. This ...

Change in policy on patient information due to judgement by the European Court of Justice

28-03-2019 | 09:30

The Medicines Evaluation Board (MEB) will no longer publish the full product information about the active substance of generic ...

Science Magazine, 7th edition: Rapid developments in advanced therapies and the vision for Regulatory Science 2025

15-03-2019 | 14:00

The MEB, the Dutch medicines authority, publishes the seventh edition of its Regulatory Science Magazine today. This edition ...

Brexit: Notification by the European Commission/EMA/CMDh and CMDv about Brexit and EU rules for batch control of medicinal products

05-03-2019 | 14:00

On 25 February 2019 the European Commission (EC) published a notice on the European rules for batch control testing of medicinal ...

News